New immunotherapy drugs are showing significant effectiveness against a broadening range of cancers, including rare cancers caused by viruses. With viruses and pathogens causing over 20 percent of all cancers, researchers believe advances in immunotherapy may lead to the treatment approach becoming an important part of the U.S.’s anti-cancer strategy. Click here to learn more about immunotherapy.
Last Updated on May 30, 2019 by Aimed Alliance
